{
    "organizations": [],
    "uuid": "ef0fa88e4e258f2dc900a15c88d7fd1e7ca15063",
    "author": "cnbc.com",
    "url": "https://www.cnbc.com/2018/02/26/the-associated-press-trovagene-reports-4q-loss.html",
    "ord_in_thread": 0,
    "title": "Trovagene reports 4Q loss",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "SAN DIEGO (AP) _ Trovagene Inc. (TROV) on Monday reported a loss of $2.6 million in its fourth quarter.\nOn a per-share basis, the San Diego-based company said it had a loss of 6 cents.\nThe molecular diagnostic company posted revenue of $185,000 in the period.\nFor the year, the company reported that its loss narrowed to $24.9 million, or 72 cents per share. Revenue was reported as $505,000.\nIn the final minutes of trading on Monday, the company's shares hit 32 cents. A year ago, they were trading at $2.\nThis story was generated by Automated Insights ( http://automatedinsights.com/ap ) using data from Zacks Investment Research. Access a Zacks stock report on TROV at https://www.zacks.com/ap/TROV",
    "published": "2018-02-27T00:47:00.000+02:00",
    "crawled": "2018-02-27T01:01:11.022+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "san",
        "diego",
        "ap",
        "trovagene",
        "trov",
        "monday",
        "reported",
        "loss",
        "million",
        "fourth",
        "quarter",
        "basis",
        "san",
        "company",
        "said",
        "loss",
        "cent",
        "molecular",
        "diagnostic",
        "company",
        "posted",
        "revenue",
        "period",
        "year",
        "company",
        "reported",
        "loss",
        "narrowed",
        "million",
        "cent",
        "per",
        "share",
        "revenue",
        "reported",
        "final",
        "minute",
        "trading",
        "monday",
        "company",
        "share",
        "hit",
        "cent",
        "year",
        "ago",
        "trading",
        "story",
        "generated",
        "automated",
        "insight",
        "http",
        "using",
        "data",
        "zacks",
        "investment",
        "research",
        "access",
        "zacks",
        "stock",
        "report",
        "trov",
        "http"
    ]
}